Your browser doesn't support javascript.
loading
Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.
Albadrani, Muayad; Seth, Ratanesh K; Sarkar, Sutapa; Kimono, Diana; Mondal, Ayan; Bose, Dipro; Porter, Dwayne E; Scott, Geoff I; Brooks, Bryan; Raychoudhury, Samir; Nagarkatti, Mitzi; Nagarkatti, Prakash; Jule, Yvon; Diehl, Anna Mae; Chatterjee, Saurabh.
Afiliación
  • Albadrani M; Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina.
  • Seth RK; Department of Family and Community Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia.
  • Sarkar S; Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina.
  • Kimono D; Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina.
  • Mondal A; Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina.
  • Bose D; Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina.
  • Porter DE; Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina.
  • Scott GI; Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, Columbia, South Carolina.
  • Brooks B; Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, Columbia, South Carolina.
  • Raychoudhury S; Department of Environmental Science, Baylor University, Waco, Texas.
  • Nagarkatti M; Departments of Biology, Chemistry, and Environmental Health Science, Benedict College, Columbia, South Carolina.
  • Nagarkatti P; Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina.
  • Jule Y; Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina.
  • Diehl AM; Biocellvia, Marseille, France.
  • Chatterjee S; Division of Gastroenterology, Duke University, Durham, North Carolina.
Am J Physiol Gastrointest Liver Physiol ; 317(4): G408-G428, 2019 10 01.
Article en En | MEDLINE | ID: mdl-31393787
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: MicroARNs / Inhibidores Enzimáticos / Proteína Fosfatasa 2 / Enfermedad del Hígado Graso no Alcohólico / NADPH Oxidasa 2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Am J Physiol Gastrointest Liver Physiol Asunto de la revista: FISIOLOGIA / GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: MicroARNs / Inhibidores Enzimáticos / Proteína Fosfatasa 2 / Enfermedad del Hígado Graso no Alcohólico / NADPH Oxidasa 2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Am J Physiol Gastrointest Liver Physiol Asunto de la revista: FISIOLOGIA / GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article